CONFIRM ANTI-PROGESTORONE RECEPTOR (1E2) RABBIT MONOCLONAL PRIMARY ANTIBODY
Nov 2011
322d
Ventana Medical Sytems, Inc. has submitted 1 FDA 510(k) premarket notifications since 2011, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Immunohistochemistry Assay, Antibody, Progesterone Receptor . Use the specialty filter in the sidebar to narrow results.